Samsung Medical (601567): Samsung Medical's re-appointment of Lixin Certified Public Accountants as the company's 2022 financial and internal control auditor CFi.CN Zhongcai Network

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000686 300049 300171 300713 300760 China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Ningbo Sanxing Medical Electric Northeast Securities Samsung Shanghai International Airport Shanghai Tofflon Science And Technology Shenzhen Mindray Bio-Medical Electronics Shenzhenrease Technology Xinjiang Sayram Modern Agriculture Science, Technology Crime, Law, Justice Litigation Arbitration Law Regulations Accounting, Audit Restructuring, Recapitalisation Management Annual, Special Corporate Meeting Annual Report Board Of Directors Research, Development Financial, Business Service Accountancy, Auditing Insurance Credit, Debt Securities Records, Achievements Employment Club, Association Civil, Public Service Reformed Pet Product, Service Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Samsung Medical (601567): Samsung Medical's re-appointment of Lixin Certified Public Accountants as the company's 2022 financial and internal control auditor CFi.CN Zhongcai Network